At 6.2% CAGR, Europe Colostrum Market is Projected to be Worth US$ 614.74 Million by 2031, says Business Market Insights

According to Business Market Insights’ research, the Europe colostrum market was valued at US$ 381.26 million in 2023 and is expected to reach US$ 614.74 million by 2031, registering a CAGR of 6.2% from 2023 to 2031. Rising awareness about health benefits of colostrum and increasing demand for colostrum from nutraceutical Industry are among the critical factors attributed to drive the Europe colostrum market growth.

Increasing health consciousness worldwide boosts the demand for nutrient-enriched products that enhance overall health. The awareness about the beneficial properties and health benefits of colostrum is increasing among consumers, which is driving the demand for colostrum-based products. Colostrum is rich in nutrients and antibodies and has immune-boosting substances. It also contains essential proteins, vitamins, minerals, and antibodies, attracting more consumers. Colostrum is recognized for its high concentration of antibodies, primarily immunoglobulins, which are pivotal in enhancing the immune system. As consumers are becoming more health-conscious and are seeking ways to improve their immune systems, there is a growing demand for colostrum-based products as a natural source of immune support. The importance of colostrum in the nutrition of babies is becoming more apparent as it fights against infections and helps overall development. This is likely to support the colostrum market's expansion over the next few years. Colostrum is rich in proteins and has low fat and sugar content. It also includes proteins such as lactoferrin (which protects against infections) and epidermal growth factor (which promotes cell growth). It also contains several essential vitamins, such as vitamin A, and minerals, such as copper, magnesium, and zinc. Colostrum has the potential to support gastrointestinal health and promote gut barrier function, making it an attractive option for individuals seeking relief from digestive issues. Thus, the rising awareness about the health benefits of colostrum worldwide is propelling the growth of the colostrum market.

On the contrary, the increasing veganism trend worldwide hampers the growth of Europe colostrum market.

Based on form, the Europe colostrum market is bifurcated into dry and liquid. The dry segment held 89.3% market share in 2023, amassing US$ 340.59 million. It is projected to garner US$ 550.68 million by 2031 to register 6.2% CAGR during 2023–2031.

In terms of category, the Europe colostrum market is bifurcated into conventional and organic. The conventional segment held 81.2% share of Europe colostrum market in 2023, amassing US$ 309.67 million. It is anticipated to garner US$ 494.50 million by 2031 to expand at 6.0% CAGR during 2023–2031.

By application, the Europe colostrum market is segmented into pharmaceuticals and dietary supplements, food and beverages, animal nutrition, and personal care. The pharmaceuticals and dietary supplements segment held 49.3% share of Europe colostrum market in 2023, amassing US$ 188.06 million. It is anticipated to garner US$ 308.01 million by 2031 to expand at 6.4% CAGR during 2023–2031.

By country, the Europe colostrum market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that the Rest of Europe captured 39.2% share of Europe colostrum market in 2023. It was assessed at US$ 149.49 million in 2023 and is likely to hit US$ 220.63 million by 2031, registering a CAGR of 5.0% during 2023–2031.

Key players operating in the Europe colostrum market are Titan Biotech Ltd, Pantheryx, Biodane Pharma A/S, Bionatin, Colostrum BioTec GmbH, Biostrum, Cure Nutraceutical PVT. LTD., INGREDIA s.r.o., I. Livanou IKE, and KERSIA GROUP, among others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com